When "minimal risk" research yields clinically-significant data, maybe the risks aren't so minimal.

Area of Science:

• Clinical research ethics
• Human subject protection
• Medical research methodology

Background:

• Research protocols involving surveys and routine clinical procedures are often classified as minimal risk.
• The minimal risk designation may lead to overlooking clinically relevant findings from research tools.
• Minimal risk research can inadvertently increase therapeutic misconception due to its similarity to clinical care.

Purpose of the Study:

• To highlight the potential for clinically relevant findings from minimal risk research procedures.
• To emphasize the need for proactive risk assessment and management in clinical research.
• To address the challenge of therapeutic misconception in minimal risk research settings.

Main Methods:

• Review of existing research on risk assessment in clinical trials.
• Analysis of the implications of using clinical tools in minimal risk research.
• Discussion of regulatory considerations for Institutional Review Boards (IRBs).

Main Results:

• Minimal risk research procedures can yield unexpected clinically relevant results.
• The therapeutic misconception is a significant risk when research mimics clinical care.
• Current risk assessment may not adequately address the potential for clinically significant incidental findings.

Conclusions:

• Investigators must anticipate clinically important findings from all research measures, regardless of risk classification.
• Explicit plans for data monitoring, disclosure, and follow-up are crucial for participant welfare.
• Institutional Review Boards (IRBs) should conduct more detailed risk assessments for protocols involving reliable clinical measures, even if categorized as minimal risk.